PSY 483 - Drugs and Behavior

Institution:
Bryant University
Subject:
Description:
Session Cycle: Fall Yearly Cycle: Every Other This course is an overview of the primary topics related to understanding drugs and their effects on human behavior. Topics include historical and methodological perspectives, basic principles of drug action, basic neurobiology, and the physiological and behavioral effects of drug use and abuse, including stimulants, depressants, narcotics, hallucinogens, designer drugs, inhalants, alcohol, tobacco, and caffeine. The course will also cover the psychopharmacology and behavioral effects of prescription psychiatric medications, including anti-depressants, anti-psychotics, anxioloytics, mood stabilizers, and hypnotics (sleep agents). Additional readings and exercises will be assigned to enhance exposure to various topics beyond the text. Current as well as classic theoretical perspectives will be emphasized throughout the course. Junior standing or permission of the instructor is required. 3.000 Credit Hours 3.000 Lecture hours Levels: Undergraduate Schedule Types: Lecture College of Arts and Sciences Undergraduate Division Applied Psychology Department Course Attributes: 400-level Psychology, Applied Psychology Major, Liberal Arts Elective, Psychology Minor, Social Science Mode of Thought
Credits:
3.00
Credit Hours:
Prerequisites:
Corequisites:
Exclusions:
Level:
Instructional Type:
Lecture
Notes:
Additional Information:
Historical Version(s):
Institution Website:
Phone Number:
(401) 232-6000
Regional Accreditation:
New England Association of Schools and Colleges
Calendar System:
Semester

The Course Profile information is provided and updated by third parties including the respective institutions. While the institutions are able to update their information at any time, the information is not independently validated, and no party associated with this website can accept responsibility for its accuracy.

Detail Course Description Information on CollegeTransfer.Net

Copyright 2006 - 2026 AcademyOne, Inc.